Metagenomi, Inc. (MGX)
NASDAQ · Healthcare
Metagenomi, Inc. Income Statement 2023–2025
| Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|
| Revenues | |||
| Revenue | 25.2M | 52.3M | 44.8M |
| Gross Profit | — | — | — |
| Profitability | |||
| Operating Income | -96.0M | -88.9M | -78.5M |
| EBITDA | — | — | — |
| Net Income | -87.9M | -78.1M | -68.3M |
| Per Share Data | |||
| EPS (diluted) | — | — | — |
| Shares Outstanding (dil.) | 37M | 33M | 3M |
Metagenomi, Inc. Income Statement — FAQ
Metagenomi, Inc. (MGX) income statement over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MGX's income statement history?
The chart and table above show Metagenomi, Inc.'s income statement by year and by quarter, including the growth rate.